C71T
CANCELLED SECTION 71
03/06/2026
Back to search
Official data from USPTO
DUOBODY
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
56
Latest update
03/31/2026
Trademark type
Combined
Nice classes
1, 5, 42, 45
Filing date
06/06/2013
Registration date
08/12/2014
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
03/06/2026
Last transaction
03/31/2026
Responsible office
United States Patent and Trademark Office
Status code
709
Official register
Principal Register
Drawing code
3
Owner type
16
Owner location
DK
Examiner
BULLOFF, TOBY ELLEN
Law office
N10
Current location
GENERIC WEB UPDATE
Holders and representatives
Holders
Genmab A/S
Representatives
Max Vern AMSTER, ROTHSTEIN & EBENSTEIN LLP
Technical classification
Nice Classes
Class 1Class 5Class 42Class 45
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Chemicalbiochemicalbiological and biotechnological preparationsespecially antibodiesbi and multi specific antibodies as well as fragmentsincluding monovalent antibodiesderivatives or conjugates of any of theseall for vitro and in vivo scientific and industrial research and development with regard to diseases
Class 5
Pharmaceutical and veterinary preparationspharmaceutical preparations based on antibodiesbi and multispecific antibodies as well as fragmentsincluding monovalent antibodiesderivatives or conjugates of any of these for use with regard to treatment of cancerinfectious diseasesimmune and autoimmune diseasesinflammatory diseasesneurodegenerative diseases and cardiovascular diseases
Class 42
Medicalscientific and biological researchespecially research into antibodies and bi and multispecific antibodies or fragmentsincluding monovalent antibodiesderivatives or conjugates of any of these and development of pharmaceutical products based on antibodies and bi and multispecific antibodies or fragmentsincluding monovalent antibodiesderivatives or conjugates of any of these; chemical analysis; computer programmingprogramming of computers for the collection and processing of medical data in medical scientific researchdevelopment and therapyincluding scientific researchdevelopment and therapy with antibodiesbi and multispecific antibodies or fragmentsincluding monovalent antibodiesderivatives or conjugates of any of these
Class 45
Legal services in the form of patent exploitation and licensing of intellectual property in the field of medicines
Publications
History of USPTO decisions and trademark events.
56 publications found
NREP
NEW REPRESENTATIVE AT IB RECEIVED
03/21/2025
EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
06/05/2024
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
06/05/2024
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
06/05/2024
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
06/05/2024
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
06/05/2024
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
06/05/2024
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
09/15/2023
REM4
COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
08/12/2023
RNWL
INTERNATIONAL REGISTRATION RENEWED
04/07/2023
INNP
PARTIAL INVALIDATION PROCESSED BY THE IB
12/25/2021
INPS
PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
11/14/2021
INPC
INVALIDATION PROCESSED
11/14/2021
INPR
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
10/24/2021
NA71
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
02/24/2021
71AG
REGISTERED-SEC.71 ACCEPTED
02/24/2021
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
02/23/2021
ES71
TEAS SECTION 71 RECEIVED
02/03/2021
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
10/26/2017
NREP
NEW REPRESENTATIVE AT IB RECEIVED
09/08/2017
NREP
NEW REPRESENTATIVE AT IB RECEIVED
04/20/2017
NREP
NEW REPRESENTATIVE AT IB RECEIVED
02/09/2017
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
02/09/2017
PRA7
REGISTERED - SEC. 7 REQUEST ABANDONED
07/27/2016
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
02/13/2015
FICS
FINAL DISPOSITION NOTICE SENT TO IB
01/27/2015
FIMP
FINAL DISPOSITION PROCESSED
01/27/2015
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
11/12/2014
PRAM
POST REGISTRATION ACTION MAILED - SEC. 7
09/22/2014
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
09/14/2014
ES7R
TEAS SECTION 7 REQUEST RECEIVED
09/04/2014
R.PR
REGISTERED-PRINCIPAL REGISTER
08/12/2014
PUBO
PUBLISHED FOR OPPOSITION
05/27/2014
GPNX
NOTIFICATION PROCESSED BY IB
05/23/2014
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
05/07/2014
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
05/07/2014
NPUB
NOTICE OF PUBLICATION
05/07/2014
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
04/24/2014
ALIE
ASSIGNED TO LIE
04/24/2014
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
04/03/2014
CNEA
EXAMINERS AMENDMENT MAILED
04/02/2014
XAEC
EXAMINER'S AMENDMENT ENTERED
04/02/2014
CNEA
EXAMINERS AMENDMENT -WRITTEN
04/02/2014
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
03/24/2014
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
03/24/2014
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
03/24/2014
RFNT
REFUSAL PROCESSED BY IB
10/16/2013
MAFR
APPLICATION FILING RECEIPT MAILED
09/24/2013
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
09/23/2013
RFRR
REFUSAL PROCESSED BY MPU
09/23/2013
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
09/21/2013
CNRT
NON-FINAL ACTION WRITTEN
09/20/2013
DOCK
ASSIGNED TO EXAMINER
09/19/2013
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
09/18/2013
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
09/13/2013
Continuous trademark protection
Get notified about every new filing that threatens DUOBODY or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.